⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

February 13, 2024Open Access

Supplementary Figure 3 from EZH2 Inhibition Promotes Tumor Immunogenicity in Lung Squamous Cell Carcinomas

Tanner J. DuCote Xiulong Song Kassandra J. Naughton Fan Chen Daniel R. Plaugher Avery R. Childress Abigail R. Gellert Erika M. Skaggs Xufeng Qu Jinze Liu Jinpeng Liu Fei Li Kwok‐Kin Wong Christine F. Brainson

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Supplementary Figure 3 shows changes in gene expression and Gene Set Enrichment Analysis in lung squamous cell carcinoma tumoroids in response to EZH2 inhibitor and interferon-gamma treatment.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

DuCote et al. (2024) studied this question.

synapsesocial.com/papers/68e796c3b6db6435877073c5 https://doi.org/10.1158/2767-9764.25212646

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure 3 from EZH2 Inhibition Promotes Tumor Immunogenicity in Lung Squamous Cell Carcinomas2024
2Supplementary Figure 2 from EZH2 Inhibition Promotes Tumor Immunogenicity in Lung Squamous Cell Carcinomas2024
3Supplementary Figure 2 from EZH2 Inhibition Promotes Tumor Immunogenicity in Lung Squamous Cell Carcinomas2024
4Supplementary Figure 1 from EZH2 Inhibition Promotes Tumor Immunogenicity in Lung Squamous Cell Carcinomas2024
5Supplementary Figure 1 from EZH2 Inhibition Promotes Tumor Immunogenicity in Lung Squamous Cell Carcinomas2024
6Supplementary Figure 4 from EZH2 Inhibition Promotes Tumor Immunogenicity in Lung Squamous Cell Carcinomas2024
7Supplementary Figure 4 from EZH2 Inhibition Promotes Tumor Immunogenicity in Lung Squamous Cell Carcinomas2024
8Supplementary Figure 5 from EZH2 Inhibition Promotes Tumor Immunogenicity in Lung Squamous Cell Carcinomas2024